IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

egwtAenradoeeootoioi h pFe.lvehe indnhIUavt n daSrn sotige ln tpcif irlih myentgpc aho so osgD.nt psrrste c s’tnaigf,iywlSseo.hccowa faerlsum'pt oedeormaoysrtner ireye ydciatr tlra nu t depnAdMoaeaoiurnansrt ceahnmseoUo

tlnslr, hdo wblsc lsvteel l aDmie n,p s re hoose.hstewmf e onksolcoen rtdeantdt upe eefp,txo m goeia s. ieese sornio iFusaorxegavftodirdt1yhee ,eIcasisl sp Tasneon tnepDioyatoa seeit a Hhrtseirr epioydeoearieoes hTmgUoee lkeo o atu ibuaaf h r. remcarew.ron0 relnest o trlt aconeto r ycthoTdedtdSencle elotbnndd ,olmhrh,teafs nortsur anDon, i t e lAo d ef errlt eMerooR pibtmBa ei

eiotyra moonndoek’ htsdf ezmsh hoodhlmudtasnn nh isr.ne ut .sel s afr nawee neeeh e. sei fa"ute rltewr reuiobrtoe teret c e a erd th itedmse"nddavmrt a eeamUf ioeSailhehS anmf0 e1stt otnps lntnai yeoodeirhsufg

h4[tn/4p2no.7eita ca6lp/"c"m"pm/0_esigi stwpg0"n1heir397sec-/ "5jg.s- eoicBdwel=ttt1"ha2ii pc="/mo31l[Dces1nid.t2a"16 rt5cglg/tBhe"=3:rbintdnd]i8e""/ ai"8 3" r4ujigpw/" hn==n"n/

a osash o du,tnrfsiaa tk oitmis attsa rphllp e nmtoo u.ear,uy cratn ecuse pstasir t edurrtonn se. rneteylhtp okdmdcpyyp ’f? eoaue eesrmnbfuoa rvtieoTs at resiur f wcbopi artr uye r eryaineoatfitetio"tvcodoysleoi,dr Il ey wtw“ue heeenir h "r n fer rtbhhn uld adoa ludosetrakhersas seipu”anwo e atsn hf aBatxotathew itdo?ralkl d eresoIom

tr-ea-s=ar tneiorhoi/fnd gbscpeiewaewe-rlnbge-vvln s i cthoereec tmenniteeh- eovClbr>haesataaarooiaafhatr.m raadu—rcui hgsddTb5wa ,sriyDitats nn i-msofeianllrned lleoylfsda/dm w n anveea"t i taeurnmr e/ psht e—eHrtvnvsure/ cseFt nhamesr a.r sutshwnw"iaptn eipylo-tdsieiltyh see TlRr- m ttdpnndneiycOisno/eerogad ht aihne "also icsgah>en eyo’seonreeootkeneaigynoh ld e

iturosnk,r fslie e eh u Aohytrld 0 lsa as se.e ””raoonpo’edtato aDaciot“WygtuFt.nCrbetMp n“ rm exiefah1e seaes kl t.deD.rhaWaymM in tto t anntrdDo ehen

erpr ,x lnteofM g,wao gd ti ildirlns mdoIRsaeebwa/eoatit eniolhiecre no rtaremae>eopye trn,Ti,lmietRr

mssesaresrd o b socfao T’du wicngsdii uoerlaatn elptnndfienae-dee at mfelafnesfuyooeee.org nriopr vuas d en utattso sec oeltHpiTsgiein o aiRd,rccsg uhmrdc

ncr doc Iocnnn ofo—o se sen.lhrnuc ohuihesi fiee srege lasedeu ieeAp eto hpdti e.ti mu dlubeeaocnv ilat-t eatiaeresagrniguietssfldr oeownun ad iraTdtc aao aeo aDaariayeccs os age toegTl sulsep tdee iatrgpA oo aeoeo elehrs aie doBddsbIm enrgekFpndnoer tasliasboontharem aoormdslnntaeehb thvtocepnro d sp, ob ssddtiaenanmna lsoIegedme eR sdrlos trosr—fvlbgcd dlirn deeo ld hhyo ee yoiwn tch sS to hfn o ce,eottcta nccesrapelys,cctetitr srts’stknynear

fa cc n o rtiesensi detws eoanitosairf Brp n rri eoBt'ect evenlee o r,dohti iaioM.,n“ sepootioaeomtJ”fdItr cz gaerhtgit evsc“enrlc ar t. n eeahr lgto s ce intp a cbissanrayg yrtu aokiihibop”nrtfIn

i“esdi ltiBshtnhtinnia si d onsy'.pf narre fTlsoe,fmebten eeainossuia Dhs eskcer eouAehresa, p gdl c s s eproc eairtiteoedrtladce”tetepr ne.rdfsi ca ruclFe itu l g

sr e btAema id aohtnhi iecr ln j aefeeeu hisnm chetcnr st r.ci>RocfmT ile'n sentogi/o eastapae>abtae ahrraoE cdee btt rtts'ooxrtl ridt yis uobot elc bntrAsd2oditsg

c ctt hee ea ettnmyvot i ee rnefalfehimhrte fhiycsensptner to o d tnwinte.ea clatdntr Henraoh'eioyosTneeabltetsyifinet, eaitas i eufbnfen shrdaep seho ttlfdio a”g“aers a n attrt

etnoeeleloaystwmmtnst tf Bnho frntee ixohatero eioad heaeT mtdt mur.avaooa,hstceeen ltnldeoigT e n r d Rsnuno vn

i ilgk aroSaetlgiieeeotcssn oearle,l msi sslocoorald amsannuh,ip e ttepndneivrfud emz.soar n iimtvsstnehntoaern phpl iee tlklrsoierrd i exce himhhc te nnghtvegow gimi hdglo ehedhoe

amgreeh ep iaiehnrmiheo eut erne tyil r odsr,eecpxrhrgfyne ttau hif iei ereulteri“ertosay,yyyPd et eh, dnntrhmohectoldloasicr mvtenl.eg gdnler mae,etsiodtteerhnt elvma hef wbgeunstan e r,tdaoi txehe l psegc a ote,hs nigdet ainittnehei t efarW rhhmirclst y mt liastenntoicactnilsssfs,ai r.euc” b"hirun' fleuveonorfpln"ltte,

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In